Dear reader,
This issue of Human Vaccines & Therapeutics starts with five articles on Acceptance, including a review immunization information systems for increased uptake (Gianfredi, p 2508), a survey of hesitancy determinants in Quebec (Guay, p 2527), an interview-based study of intervention to promote maternal vaccination mediated by midwives (Kaufman, p 2534), assessment of knowledge and attitudes to pediatric vaccines in Malaysian mothers (Balbir Singh, p 2544), and a Letter to the Editor on the value and measurement of vaccine literacy (Biasio, p 2552).
Seven research articles on Licensed Vaccines investigate the impact of universal vaccination on trends in varicella and herpes zoster epidemiology (Choi, p 2554) — see also the associated Letter to the Editor (Lai, p 2561) and a Response Letter (Park, p 2562) — the sero-epidemiology of pertussis in Hangzhou, China (Xu, p 2564), economic burden of measles in Zhejiang, China (Deng, p 2571), vaccine effectiveness in HIV-infected and exposed children (Adetokunboh, p 2578), burden of vaccine-preventable diseases among these children in sub-Saharan Africa (Adetokunboh, p 2590), influenza and pneumococcal vaccination rates among patients with acute respiratory failure (Candemir, p 2606), and a case of rabies post-exposure prophylaxis failure (Bharti, p 2612).
In the Influenza section, we present two reviews of the insights into vaccination and host responses from transcriptomics (Rao, p 2615) and implementation of yearly enhanced safety surveillance in Europe (Dos Santos, p 2624), and two research articles on low awareness about vaccination among Chinese pregnant women and their obstetricians (Wang, p 2637) and coverage among splenectomy patients in Italy (Bianchi, p 2644).
The segment on Public Health introduces a study of quality improvement approaches for reducing missed opportunities for childhood vaccination (Adamu, p 2650), and two mini-reviews on the importance of affordable pediatric vaccines (Kaufmann, p 2660) and vaccine stock management in healthcare facilities (Iwu, p 2666).
The Novel Vaccines section features a review of human CMV vaccine development (Cui, p 2673) and a study on the efficacy of a novel recombinant vaccine against RSV (Li, p 2684).
We present two articles on Immunotherapy: a policy & status paper on the development of therapeutic MAbs in China (Jiang, p 2695) and a commentary on determining patent eligibility for immunotherapy products (Wang, p 2706).
Two Pneumococcal articles include a systematic review of comparative efficacy of PCVs (McGirr, p 2713) and a commentary on serotype shifts (Dobay, p 2725).
Finally, we introduce a review of the two-dose schedule of the Meningococcal MenB-FHbp vaccine (McDaniel, p 2729), analysis of B- and T-cell receptor diversity in response to Hepatitis B vaccine (Miyasaka, p 2738), a systematic review of Rotavirus disease burden (Badur, p 2754), a Clinical paper on a rare adverse event, the Arthus reaction (Peng, p 2769), and a Technology commentary on the Neisseria PorB protein as adjuvant (Yuen, p 2778).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss, PhD
Acquisitions Editor